heart attack

Views & Analysis

Recent research suggests that the ways in which men and women describe heart attack symptoms differently can affect diagnosis in urgent situations.

News

Novartis to discuss canakinumab results with regulators.

Oncology

At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.